Lili Zhou, Botao Wang, Ping Li, Yan Lu, Shiguang Ye, Shaoguang Li, Aibin Liang. "Glofitamab effectively bridging CD19-specific CAR T- cell therapy while maintaining safety in patients with refractory DLBCL." Blood, 2025. doi:10.1182/blood-2025-7265